(UroToday.com) In the Controversies in the Management of Kidney Cancer session of this year’s virtual Société Internationale d’Urologie (SIU) annual congress, Dr. Axel Bex and Dr. Jose Karam debated the role of cytoreductive nephrectomy with kidney cancer, taking the con and pro sides of this argument, respectively. Dr. Karam began highlighting the cases of three patients: